Reducing Obesity with Drugs has Nasty side-effects

Anti-obesity drugs have always been shadowed by reports of side-effects that can sometimes be fatal. The last drug to receive FDA nod was discontinued after a year.

A fortnight ago ( July 2012), the United States Food and Drug Administration (USFDA) gave its approval to an anti-obesity drug lorcaserin (trade name Belviq) for the first time in 13 years.

In the last five years, two so-called obesity panaceas have been banned in India. There is only one approved anti-obesity drug in India, which is only mildly effective.

"Any anti-obesity drug is welcome, but given the dismal history of anti-obesity drugs, I am not enthusiastic about these. I may still use it for want of anything better, but not too frequently," says Dr Amrish Mithal, chairman and head of the department of endocrinology and diabetes at Medanta Medicity

It is an accepted fact that anti-obesity drugs are tricky business. In the 1990s, an anti-obesity drug combining fenfluramine and phentermine popularly known as fen-phen is known to have invited around 50,000 product liability lawsuits amounting to claims of $14 billion. Fen-phen was associated with pulmonary hypertension and heart valve problems, and was withdrawn later.

In Indian TV channels, a lot of money is spent by so called ayurvedic drugs companies to advertise products to reduce your weight, to grow tall, to become fairer etc etc. You can trust these companies only at your own risk. Best is to avoid fatty foods, eliminate fast foods and do reasonable amount of walking and exercises.

By the way these Fair Skin companies, did they sell their creams in Norway and Sweden? Is that why they are so fair-skinned? Better for them to sell their creams in Africal countries and they will make tonnes and tonnes of money and Swiss banks will be happy too.